Technological Platforms

Home / About us / Innovation / Technological Platforms

We develop unique and differentiated products due to their dosing, release, protection and safety system, associations of active ingredients and presentation.

We manufacture and market over-the-counter (OTC), prescription drugs, nutritional supplements, and high-potential clinical solutions that make up a complete portfolio of dosage forms.

Softgel

SGC is a solid dosage form comprised of two gelatin films containing semi-solid or liquid APIs protected by a hermetically sealed outer shell.

Softgels ensure high-precision dosing by achieving ingredient homogeneity.

An effective delivery system for oral drugs, especially those with low solubility and/or permeability (BCS class II, III, and IV (1)).

Unigel™

Technological platform that allows the manufacture of Soft Gelatin Capsules that contain tablets, capsules, granules, or pellets inside, making possible combinations of doses.

Unigel™ (US Patent No. 8,967,989B2) is the only patented technology for fixed-dose combinations that incorporates the benefits of Soft Gelatin Capsules.

Watch video

Versagel™

Technological platform that allows the production of Soft Capsules free of derivatives of animal origin. It is compatible with the contents of Soft Gelatin Capsule and with high pH contents. It has a coating resistant to high temperatures (process, storage and transport).

VersagelTM Consumer Benefits:

It has the same advantages as the Soft Gelatin Capsule, but is free of animal derivatives.
It is available in the same range of shapes and sizes as the Soft Gelatin Capsules.
It is compatible with current types of Softgel content but with a greater acceptability range of pH.